Institute of Technology, University of Tartu, Tartu, Estonia.
Icosagen AS, Õssu, Tartumaa, Estonia.
J Virol. 2019 Aug 28;93(18). doi: 10.1128/JVI.00794-19. Print 2019 Sep 15.
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus. It has a positive-sense RNA genome that also serves as the mRNA for four nonstructural proteins (nsPs) representing subunits of the viral replicase. Coupling of nsP and RNA synthesis complicates analysis of viral RNA replication. We developed -replication systems, where production of replication-competent RNA and expression of viral replicase are uncoupled. Mammalian and mosquito RNA polymerase I promoters were used to produce noncapped RNA templates, which are poorly translated relative to CHIKV replicase-generated capped RNAs. It was found that, in human cells, constructs driven by RNA polymerase I promoters of human and Chinese hamster origin performed equally well. In contrast, RNA polymerase I promoters from mosquitoes exhibited strong species specificity. In both mammalian and mosquito cells, novel -replicase assays had exceptional sensitivity, with up to 10-fold higher reporter expression in the presence of replicase relative to background. Using this highly sensitive assay to analyze CHIKV nsP1 functionality, several mutations that severely reduced, but did not completely block, CHIKV replicase activity were identified: (i) nsP1 tagged at its N terminus with enhanced green fluorescent protein; (ii) mutations D63A and Y248A, blocking the RNA capping; and (iii) mutation R252E, affecting nsP1 membrane anchoring. In contrast, a mutation in the nsP1 palmitoylation site completely inactivated CHIKV replicase in both human and mosquito cells and was lethal for the virus. Our data confirm that this novel system provides a valuable tool to study CHIKV replicase, RNA replication, and virus-host interactions. Chikungunya virus (CHIKV) is a medically important pathogen responsible for recent large-scale epidemics. The development of efficient therapies against CHIKV has been hampered by gaps in our understanding of how nonstructural proteins (nsPs) function to form the viral replicase and replicate virus RNA. Here we describe an extremely sensitive assay to analyze the effects of mutations on the virus RNA synthesis machinery in cells of both mammalian (host) and mosquito (vector) origin. Using this system, several lethal mutations in CHIKV nsP1 were shown to reduce but not completely block the ability of its replicase to synthesize viral RNAs. However, in contrast to related alphaviruses, CHIKV replicase was completely inactivated by mutations preventing palmitoylation of nsP1. These data can be used to develop novel, virus-specific antiviral treatments.
基孔肯雅病毒(CHIKV)是一种蚊媒甲病毒。它具有正链 RNA 基因组,该基因组也作为四个非结构蛋白(nsP)的 mRNA,代表病毒复制酶的亚基。nsP 与 RNA 合成的偶联使病毒 RNA 复制的分析复杂化。我们开发了 -复制系统,其中复制酶产生的有活性的 RNA 和病毒复制酶的表达是解偶联的。使用哺乳动物和蚊子 RNA 聚合酶 I 启动子来产生非帽 RNA 模板,相对于 CHIKV 复制酶产生的帽 RNA,这些模板的翻译效率较差。结果发现,在人细胞中,来源于人源和中国仓鼠来源的 RNA 聚合酶 I 启动子驱动的构建体表现出相同的效果。相比之下,来自蚊子的 RNA 聚合酶 I 启动子表现出强烈的种特异性。在哺乳动物和蚊子细胞中,新型 -复制酶测定法具有极高的灵敏度,与背景相比,在存在复制酶的情况下,报告基因的表达提高了 10 倍。使用这种高度灵敏的测定法分析 CHIKV nsP1 功能,鉴定出几个严重降低但不完全阻断 CHIKV 复制酶活性的突变:(i)nsP1 在其 N 末端标记有增强型绿色荧光蛋白;(ii)突变 D63A 和 Y248A,阻断 RNA 加帽;和(iii)突变 R252E,影响 nsP1 膜锚定。相比之下,nsP1 棕榈酰化位点的突变完全使 CHIKV 复制酶在人源和蚊源细胞中失活,并且对病毒是致命的。我们的数据证实,该新型系统为研究 CHIKV 复制酶、RNA 复制和病毒-宿主相互作用提供了有价值的工具。基孔肯雅病毒(CHIKV)是一种具有医学重要性的病原体,导致了最近的大规模流行。由于我们对非结构蛋白(nsP)如何形成病毒复制酶并复制病毒 RNA 的功能的了解存在差距,因此针对 CHIKV 的有效疗法的开发受到了阻碍。在这里,我们描述了一种非常灵敏的测定法,用于分析突变对来自哺乳动物(宿主)和蚊子(载体)来源的细胞中的病毒 RNA 合成机制的影响。使用该系统,鉴定出 CHIKV nsP1 的几个致死突变可降低但其复制酶合成病毒 RNA 的能力,但不能完全阻断。然而,与相关的甲病毒不同,CHIKV 复制酶完全失活是由于突变阻止了 nsP1 的棕榈酰化。这些数据可用于开发新型的、针对病毒的抗病毒治疗方法。
Nat Commun. 2024-1-2
Methods Mol Biol. 2024
Methods Mol Biol. 2024
Proc Natl Acad Sci U S A. 2023-9-12
Proc Natl Acad Sci U S A. 2019-4-18
Proc Natl Acad Sci U S A. 2018-10-15
J Gen Virol. 2018-5-10